ACCO Brands Raised Its Outlook, but the 2% Organic Sales Decline Is the Real Story

ACCO's 5% sales growth masked a 2% organic decline

ACCO Brands looked stronger at first glance, but the underlying demand signal was less encouraging. Management can point to second-quarter sales rose 5% and a raised full-year outlook, yet the cleaner read is that comparable sales declined 2%. In other words, the core business did not broadly accelerate. The reported sales gain came mainly from the EPOS acquisition and favorable foreign-exchange effects, while management also highlighted its multiyear cost-reduction program. That is quite different from healthy organic demand.

Why the Oct. 29, 2026 call matters

This is the tension investors need to keep in mind: cost cuts can support profits for a while, but a more durable rerating usually requires evidence that customers are buying more. ACCO itself did not sound fully confident on demand, retaining a cautious view of demand in the second half even after improving guidance.

That is why the Oct. 29, 2026 earnings call matters. Investors need to see whether the next quarter reflects stronger end demand or another quarter in which ACCO improved results more through savings and acquisitions than through core sales momentum.

The raised outlook looks supported by savings, EPOS, and seasonal strength

How the guidance raise breaks down

Management did not simply lift numbers out of thin air. ACCO now expects 2%–5% reported sales growth and adjusted EPS of $0.87–$0.91. More important, it tied that improvement to identifiable drivers: a stronger Americas business, EPOS integration, operating savings, and better back-to-school momentum. That makes the raise more understandable, but also less broad-based than it first appears.

The Americas did much of the work. In the Americas segment, sales rose 6% and comparable sales increased 2%, helped by strong North American back-to-school placements and better conditions in Mexico. At the same time, EPOS is now being absorbed into the base case, with the company targeting approximately $80 million in 2026 sales and $15 million in synergies. Add in the impact of cost cuts, and the new range becomes easier to build even if the core organic engine is not dramatically healthier.

What the raise does and does not prove

The more balanced takeaway is this: the raised outlook looks savings-backed and acquisition-assisted, not clearly driven by broader product demand. That is enough to keep the business from weakening quickly, but it is not the same as proving stronger consumer pull across the portfolio.

If the next update shows that EPOS and cost savings did most of the work while soft enterprise, PC-accessory and gaming demand is expected to persist through the second half, investors will have to decide whether a savings-backed raise deserves a premium valuation.

The key question for the next update

The July 30, 2026 EPS beat shows investors responded positively to the cleaner headline. It does not, by itself, prove that demand across shelves and markets has materially improved.

What to watch on the call

• Are comp sales turning positive again? Last quarter, comparable sales declined 2%. That remains the core test of underlying demand.
• Is strength broadening beyond back-to-school? Management highlighted early back-to-school indicators have been favorable, but investors need evidence that the strength is lasting and spreading.
• Are weaker segments stabilizing? Pay close attention to whether soft enterprise, PC-accessory and gaming demand is holding up or continuing to drag on results.

My stance remains cautious. The setup improves only if comp sales turn positive and Americas strength broadens beyond the seasonal rush. Otherwise, this still looks more like a savings-assisted improvement than clear proof of stronger brand pull.